Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 255-485-3 | CAS number: 41669-30-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral (OECD 422), rat: NOAEL (systemic):
Females = 300 mg/kg bw/day
Males = ≥ 1000 mg/kg bw/day
Oral (OECD 408), rat: NOAEL (systemic) = ≥ 1000 mg/kg bw/day
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises adequate, reliable (Klimisch score 2 due to read-across) and consistent studies from reference substances with similar structure and intrinsic properties (refer to endpoint discussion for further details). The available studies are sufficient to fulfil the standard information requirements set out in Annex VIII-IX, 8.6, in accordance with Annex VIII, 1.5, of Regulation (EC) No 1907/2006..
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for read-across
There are no data available on the repeated dose toxicity of isooctadecyl isooctadecanoate (CAS 41669-30-1). In order to fulfil the standard information requirements set out in Annex IX, 8.6, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006, read-across from structurally related substances was conducted.
In accordance with Article 13 (1) of Regulation (EC) No 1907/2006, "information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI are met.” In particular for human toxicity, information shall be generated whenever possible by means other than vertebrate animal tests, which includes the use of information from structurally related substances (grouping or read-across to avoid the need to test every substance for every endpoint).
Overview of repeated dose toxicity
CAS |
Chemical name |
Molecular weight |
Repeated dose toxicity: oral |
41669-30-1 |
isooctadecyl isooctadecanoate |
536.95 |
RA: CAS 868839-23-0 + CAS 59231-34-4 |
868839-23-0 |
propylheptyl octanoate |
284.48 |
Experimental result (OECD 408): |
59231-34-4 |
isodecyl oleate |
422.73 |
Experimental result (OECD 422): NOAEL females = 300 mg/kg bw/d NOAEL males = ≥ 1000 mg/kg bw/day |
The above mentioned substances are considered to be similar to each other based on structurally similar properties and/or activities. Therefore, available data on the source substances has been read-across to isooctadecyl isooctadecanoate (CAS 41669-30-1).
The target substance is characterized as an UVCB substance comprised of a branched C18 fatty acid esterified with an aliphatic, but branched C16 and C18 alcohol. The source substances are structurally similar to the target substance. Propylheptyl octanoate (CAS 868839 -23-0) is a mono-constituent substance consisting of stearic acids esterified with propylheptanol. Isodecyl oleate (CAS 59231-34-4) is an UVCB substance consisting of oleic acid esterified with a branched alcohol (decanol). A detailed analogue approach justification is provided in the technical dossier (see IUCLID Section 13).
CAS 868839-23-0
A repeated dose toxicity study was performed in rats according to OECD 408, using propylheptyl octanoate (CAS 868839-23-0) (Leuschner, 2006). 10 Wistar rats/sex/dose were administered 100, 300 and 1000 mg/kg bw/day of the test substance in soybean oil by gavage, for 90 consecutive days.
1/10 females in each of the low-, mid- and high dose groups, respectively, died during the laboratory examinations on the last treatment day after blood withdrawal. These deaths are considered to be caused by the ether narcosis and are therefore not treatment-related. No treatment-related clinical signs were observed. No treatment-related effects were noted on body weight, body weight gain, food consumption and water consumption. The ophthalmoscopic examination did not show treatment-related effects on the eyes. No treatment-related effects were observed during the neurobehavioral and observational tests. There were no statistically significant differences in the haematology parameters between the control group and the treatment groups. The albumin and blood urea nitrogen levels were significantly increased in the males in the high-dose group. As no effects were noted on these parameters in the females of the high-dose group, and in the absence of related histopathological findings, these effects are not considered to be toxicologically relevant. A statistically significant decrease in urinary pH value was noted in males in the mid-dose group and in males and females in the high-dose groups. This is considered to be a treatment-related, but not toxicologically relevant, effect as no other effects on urinary parameters or kidney histopathology was noted. The absolute and relative liver weight in high-dose males and females was significantly increased. This is probably an adaptive response to the increased metabolic load due to ingestion of the test substance. As no related effects were noted on liver enzyme levels or liver histopathology, this is not considered to be a toxicologically relevant effect. There were no statistically significant differences in the mean length of the oestrus cycles and the number of complete cycles between the females in the control group and the treatment groups. In males, there were no statistically significant differences between the control group and the treatment groups in the mean number and percentage of ultrasound-resistant spermatids, number of motile spermatozoa in the cauda epididymis, and in the percentage of spermatids with malformations. No treatment-related gross pathological or histopathological effects were observed in organs or tissues.
Based on the lack of toxicologically relevant effects up to and including the highest dose level, the NOAEL is considered to be ≥ 1000 mg/kg bw/day.
CAS 59231-34-4
A combined repeated dose toxicity and reproduction/developmental toxicity screening study (according to OECD 422 under GLP conditions) was performed with isodecyl oleate (Hansen, 2013). 10 rats/sex/dose were administered 100, 300 and 1000 mg/kg bw/day isodecyl oleate once daily for 28 day (males) and up to 54 days (females) via gavage. The application started two weeks before mating on test Day 1 and ended on the day or one day before sacrifice. Day of sacrifice was on test Day 36 for the male rats and on lactation Day 4 or shortly thereafter for the female rats. No test item-related premature death was noted. No test item-related signs of toxicity were noted during the observational and neurological screenings. A test item-related decrease in body weight was noted for the female animals of the high dose group (1000 mg /kg bw/day) only on lactation Day 4. A test item-related decrease in food consumption was noted for the female animals of the high dose group (1000 mg/kg bw/day) during the lactation/gestation period. No test item-related changes were noted for the haematological parameters and the parameters of clinical chemistry. Macroscopic inspection at autopsy revealed no test item related changes. The histopathological examination revealed no test item-related changes. No other effect was observed in any further group or any parameter. The effects observed at 1000 mg/kg bw/d in the females were considered adverse and leading to maternal toxicity; thus, the NOAEL for systemic toxicity was determined to be 300 mg/kg bw/day in females and 1000 mg/kg bw/d in male rats in this study.
Conclusions on repeated dose toxicity
Based on the available 90-d and combined repeated dose/reproduction/developmental toxicity screening test studies with the structural analogous substances, propylheptyl octanoate (CAS 868839-23-0) and isodecyl oleate (CAS 59231-34-4), the overall sub-acute and sub-chronic NOAEL, for isooctadecyl isooctadecanoate, is therefore considered to be 300 mg/kg bw/day based on the adverse effects observed in the OECD 422 screening study at a dose level of 1000 mg/kg bw/d (Hansen, 2013).
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Hazard assessment is conducted by means of read-across from structural analogues. All available studies are adequate and reliable based on the identified similarities in structure and intrinsic properties between the source and target substances and overall quality assessment (refer to the endpoint discussion for further details). The study with the lowest dose descriptor was chosen for chemical safety assessment.
Justification for classification or non-classification
Based on read-across from structurally similar substances, the available data on repeated dose toxicity via the oral route do not meet the classification criteria according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.